Telehealth Response for E-prescribing Addiction Therapy Services Act

The TREATS Act amends the Controlled Substances Act to allow healthcare providers to use telehealth for the initial evaluation when prescribing certain medications for opioid use disorder. Specifically, it replaces the requirement for an in-person medical evaluation with an option for a telehealth evaluation for medications in schedules III, IV, or V (excluding methadone) that are FDA-approved to treat opioid use disorder. The telehealth evaluation must be conducted via real-time audio or video communication meeting federal and state requirements, as defined by the bill. This change directly affects providers prescribing these medications and patients seeking treatment for opioid use disorder in these categories.